SCHEMBL9714680

SCHEMBL9714680

CC(C#N)CN(C)c1cccc(CCl)c1.c1ccc(P(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MAOB P27338 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9714816 0.80 SLC6A2 (0.34) MAOB
SCHEMBL9714646 0.78 MEN1 (0.35)
SCHEMBL9714665 0.76 SGMS2 (0.39) MAOB
Hydrochloric Acid SCHEMBL9714685 0.76 MAOB (0.36) MAOB
SCHEMBL9714823 0.75 MAOA (0.35) MAOB
SCHEMBL9714779 0.75 CYP3A4 (0.33) MAOB
SCHEMBL9714712 0.73 TSHR (0.36) MAOB
SCHEMBL9714488 0.72 CYP3A4 (0.36) MAOB
SCHEMBL9714829 0.70 CYP3A4 (0.34)
SCHEMBL9714754 0.70 KDM4E (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5166210-A QUINOLINE DERIVATIVES AS ANTAGONISTS OF LEUKOTRIENE D4 RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1992-11-24 US disclosed
US-5028615-A Treatment of hypersensitivity RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1991-07-02 US disclosed
US-4920133-A Quinoline derivatives and use thereof as antagonists of leukotriene D4 RORER PHARMACEUTICAL CORP. (US) 1990-04-24 US disclosed